Cost-effectiveness of 2 + 1 dosing of 13-valent and 10-valent pneumococcal conjugate vaccines in Canada

BACKGROUND: Thirteen-valent pneumococcal conjugate vaccine (PCV13) and 10-valent pneumococcal conjugate vaccine (PCV10) are two recently approved vaccines for the active immunization against Streptococcus pneumoniae causing invasive pneumococcal disease in infants and children. PCV13 offers broader...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Earnshaw, Stephanie R, McDade, Cheryl L, Zanotti, Giovanni, Farkouh, Raymond A, Strutton, David
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2012
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3532329/
https://ncbi.nlm.nih.gov/pubmed/22530841
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2334-12-101
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky